Magsalay, Revel .
HRN: 24-30-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2023
METRONIDAZOLE 500MG (TAB)
12/26/2023
01/01/2024
PO
500mg
TID
Thickly Msaf
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes